547 related articles for article (PubMed ID: 18063918)
21. The pharmacology of LXR.
Michael LF; Schkeryantz JM; Burris TP
Mini Rev Med Chem; 2005 Aug; 5(8):729-40. PubMed ID: 16101409
[TBL] [Abstract][Full Text] [Related]
22. SREBP-2 positively regulates transcription of the cholesterol efflux gene, ABCA1, by generating oxysterol ligands for LXR.
Wong J; Quinn CM; Brown AJ
Biochem J; 2006 Dec; 400(3):485-91. PubMed ID: 16901265
[TBL] [Abstract][Full Text] [Related]
23. Liver X receptor: a cardinal target for atherosclerosis and beyond.
Parikh M; Patel K; Soni S; Gandhi T
J Atheroscler Thromb; 2014; 21(6):519-31. PubMed ID: 24695022
[TBL] [Abstract][Full Text] [Related]
24. Sterol intermediates from cholesterol biosynthetic pathway as liver X receptor ligands.
Yang C; McDonald JG; Patel A; Zhang Y; Umetani M; Xu F; Westover EJ; Covey DF; Mangelsdorf DJ; Cohen JC; Hobbs HH
J Biol Chem; 2006 Sep; 281(38):27816-26. PubMed ID: 16857673
[TBL] [Abstract][Full Text] [Related]
25. Liver X receptors and the control of cholesterol homeostasis: potential therapeutic targets for the treatment of atherosclerosis.
Millatt LJ; Bocher V; Fruchart JC; Staels B
Biochim Biophys Acta; 2003 Mar; 1631(2):107-18. PubMed ID: 12633677
[TBL] [Abstract][Full Text] [Related]
26. Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells.
DiBlasio-Smith EA; Arai M; Quinet EM; Evans MJ; Kornaga T; Basso MD; Chen L; Feingold I; Halpern AR; Liu QY; Nambi P; Savio D; Wang S; Mounts WM; Isler JA; Slager AM; Burczynski ME; Dorner AJ; LaVallie ER
J Transl Med; 2008 Oct; 6():59. PubMed ID: 18925943
[TBL] [Abstract][Full Text] [Related]
27. Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia.
Kratzer A; Buchebner M; Pfeifer T; Becker TM; Uray G; Miyazaki M; Miyazaki-Anzai S; Ebner B; Chandak PG; Kadam RS; Calayir E; Rathke N; Ahammer H; Radovic B; Trauner M; Hoefler G; Kompella UB; Fauler G; Levi M; Levak-Frank S; Kostner GM; Kratky D
J Lipid Res; 2009 Feb; 50(2):312-26. PubMed ID: 18812595
[TBL] [Abstract][Full Text] [Related]
28. Functional crosstalk of CAR-LXR and ROR-LXR in drug metabolism and lipid metabolism.
Xiao L; Xie X; Zhai Y
Adv Drug Deliv Rev; 2010 Oct; 62(13):1316-21. PubMed ID: 20659512
[TBL] [Abstract][Full Text] [Related]
29. Reciprocal negative cross-talk between liver X receptors (LXRs) and STAT1: effects on IFN-γ-induced inflammatory responses and LXR-dependent gene expression.
Pascual-García M; Rué L; León T; Julve J; Carbó JM; Matalonga J; Auer H; Celada A; Escolà-Gil JC; Steffensen KR; Pérez-Navarro E; Valledor AF
J Immunol; 2013 Jun; 190(12):6520-32. PubMed ID: 23686490
[TBL] [Abstract][Full Text] [Related]
30. Liver X receptors as integrators of metabolic and inflammatory signaling.
Zelcer N; Tontonoz P
J Clin Invest; 2006 Mar; 116(3):607-14. PubMed ID: 16511593
[TBL] [Abstract][Full Text] [Related]
31. Regulation of bile acid, cholesterol, and fatty acid synthesis in chicken primary hepatocytes by different concentrations of T0901317, an agonist of liver X receptors.
Sato K; Kamada T
Comp Biochem Physiol A Mol Integr Physiol; 2011 Feb; 158(2):201-6. PubMed ID: 21056113
[TBL] [Abstract][Full Text] [Related]
32. Suppression of 2,3-oxidosqualene cyclase by high fat diet contributes to liver X receptor-alpha-mediated improvement of hepatic lipid profile.
Dang H; Liu Y; Pang W; Li C; Wang N; Shyy JY; Zhu Y
J Biol Chem; 2009 Mar; 284(10):6218-26. PubMed ID: 19119143
[TBL] [Abstract][Full Text] [Related]
33. LuXuRies of lipid homeostasis: the unity of nuclear hormone receptors, transcription regulation, and cholesterol sensing.
Zhang Y; Mangelsdorf DJ
Mol Interv; 2002 Apr; 2(2):78-87. PubMed ID: 14993353
[TBL] [Abstract][Full Text] [Related]
34. Non-steroidal LXR agonists; an emerging therapeutic strategy for the treatment of atherosclerosis.
Bennett DJ; Cooke AJ; Edwards AS
Recent Pat Cardiovasc Drug Discov; 2006 Jan; 1(1):21-46. PubMed ID: 18221072
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of liver x receptor/retinoid X receptor-mediated transcription contributes to the proatherogenic effects of arsenic in macrophages in vitro.
Padovani AM; Molina MF; Mann KK
Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1228-36. PubMed ID: 20339114
[TBL] [Abstract][Full Text] [Related]
36. Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR.
Calkin AC; Tontonoz P
Nat Rev Mol Cell Biol; 2012 Mar; 13(4):213-24. PubMed ID: 22414897
[TBL] [Abstract][Full Text] [Related]
37. Oxysterols, cholesterol homeostasis, and Alzheimer disease.
Vaya J; Schipper HM
J Neurochem; 2007 Sep; 102(6):1727-1737. PubMed ID: 17573819
[TBL] [Abstract][Full Text] [Related]
38. Assessing the effects of LXR agonists on cellular cholesterol handling: a stable isotope tracer study.
Aravindhan K; Webb CL; Jaye M; Ghosh A; Willette RN; DiNardo NJ; Jucker BM
J Lipid Res; 2006 Jun; 47(6):1250-60. PubMed ID: 16567856
[TBL] [Abstract][Full Text] [Related]
39. LXR agonists for the treatment of atherosclerosis.
Jaye M
Curr Opin Investig Drugs; 2003 Sep; 4(9):1053-8. PubMed ID: 14582448
[TBL] [Abstract][Full Text] [Related]
40. Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes.
Proctor G; Jiang T; Iwahashi M; Wang Z; Li J; Levi M
Diabetes; 2006 Sep; 55(9):2502-9. PubMed ID: 16936198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
